Jaguar Health, Inc. (JAGX)
0.382
-0.01
(-2.05%)
USD |
NASDAQ |
Apr 14, 12:36
Jaguar Health EPS Diluted (Quarterly) : -3.326 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Tonix Pharmaceuticals Holding Corp. | -3.976 |
| Phio Pharmaceuticals Corp. | -0.2041 |
| MetaVia, Inc. | -0.8361 |
| Seastar Medical Holding Corp. | -0.8018 |
| Jupiter Neurosciences, Inc. | -0.0748 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -23.19M |
| Revenue (Quarterly) | 3.235M |
| Total Expenses (Quarterly) | 26.30M |
| Enterprise Value | 37.35M |
| Gross Profit Margin (Quarterly) | 15.21% |
| Profit Margin (Quarterly) | -716.9% |
| Earnings Yield | -9.57K% |
| Normalized Earnings Yield | -8315.10 |